Skip to main content

Nurses providing medical aesthetics are providing health services and therefore all the standards of practice apply. 

Is administering Botox® and dermal fillers within the nursing scope of practice?

Both Botulinum Toxin Type A and Type B (e.g. Botox®) and dermal filler administration are within the nursing scope of practice as set out in the nursing regulations. Botox® is a Schedule I medication, and most dermal fillers are either Schedule II medications or substances. 

Nurses:

  • require a client-specific order when administering Schedule I medications and all dermal fillers.
  • ensure they can meet all relevant BCCNM standards of practice.
  • have the knowledge, skills, and judgment (competence) prior to performing any nursing activity.
  • are aware of any restrictions or conditions that other health professionals may have related to the activity.
  • are aware of resources and supports available in their practice setting to manage unintended outcomes.

Specifically, LPNs administer

  • Botulinum Toxin Type A products:
    a) After successfully completing additional education
    b) When the ordering health professional is immediately available
  • Dermal fillers for cosmetic purposes:
    a) After successfully completing additional education
    b) When the ordering health professional is immediately available

Scenario

Vashti is interested in practising nursing in medical aesthetics. She researches the competencies she needs to work in this area; she enrolls in education to gain these competencies.

Before her first day at her new job, Vashti:

Need help or advice?

Talk to one of our regulatory practice consultants. Consultation is available by

External resources

Related BCCNM public notices

Review the following consent agreements to see how not meeting BCCNM Standards of Practice can impact your nursing practice.